Download EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023 Brochure

Brochure
More information from http://www.researchandmarkets.com/reports/2819213/
EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
Description:
EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
Summary
Atrial fibrillation (AF) is a disorder of the heart’s electrical system. The condition is characterized by an
irregular heart rhythm that is either too fast or too slow. During AF, the two upper chambers of the heart
(atria) beat out of coordination with the two lower chambers (ventricles) due to disorganized electrical
signals, resulting in poor blood supply to the lungs and the rest of the body. The symptoms of AF typically
include heart palpitations, irregular and fast heartbeat, chest discomfort, shortness of breath, dizziness, and
weakness. However, individuals with AF may be asymptomatic and not even know that they have the
condition until it is identified through an electrocardiogram (EKG or ECG) test.
AF is one of the most common cardiovascular diseases among the elderly, worldwide. Although AF affects
people of all ages, the condition is rare in individuals younger than 40 years of age. The risk for AF increases
rapidly with age and is more common in men than women. Globally, the prevalence of AF varies widely,
depending on the country and the study, ranging from 0.1-1.6% in Asia (0.1% in India, 1.6% in Japan), 0.953.9% in North America (0.95% in the US, 3.9% in Canada), 1.28-2.1% in Europe (1.28% in the UK, 2.1% in
Germany), and 4.0% in Australia.
The publisher epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by
21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed
prevalent cases in 2023.
Our epidemiological forecast for the diagnosed prevalent cases of AF in the 8MM is supported by
epidemiologic data from country-specific studies that are nationally representative of the entire population
in these markets. This analysis included the most recently published nationally-representative studies in the
8MM, which provided the diagnosed prevalence of AF using uniform diagnostic criteria based on EKG tests,
which facilitated a meaningful comparison of the forecast for the diagnosed prevalent cases of AF in the
8MM.
Scope
- The Atrial Fibrillation (AF) EpiCast Report provides an overview of the risk factors, comorbidities, and the
global and historical trends for AF in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK,
Japan, and Canada). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of AF
segmented by sex, age (in five-year age groups, beginning at 40 years and ending at =85 years), and clinical
subtypes (paroxysmal, persistent, and permanent AF) in these markets.
- The AF epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of
disease trends in the 8MM.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global AF market.
- Quantify patient populations in the global AF market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best
opportunities for AF therapeutics in each of the markets covered.
Contents:
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global Trends
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Forecast Assumptions and Methods
3.4.3 Sources Not Used
3.5 Epidemiological Forecast for Atrial Fibrillation (2013-2023)
3.5.1 Diagnosed Prevalent Cases of Atrial Fibrillation
3.5.2 Age-Specific Diagnosed Prevalent Cases of Atrial Fibrillation
3.5.3 Sex-Specific Diagnosed Prevalent Cases of Atrial Fibrillation
3.5.4 Age-Standardized Diagnosed Prevalence of Atrial Fibrillation
3.5.5 Diagnosed Prevalent Cases of Atrial Fibrillation by Clinical Subtypes
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head of Healthcare
4.3 About Us
4.4 About EpiCast
4.5 Disclaimer
1.1 List of Tables
Table 1: Clinical Subtypes of AF
Table 2: Risk Factors and Comorbidities for AF
Table 3: Diagnosed Prevalence (%) of AF in the 6MM,- as Reported in Epidemiological Studies
Table 4: Total Prevalence (%) of AF in the 7MM,- as Reported in Epidemiological Studies
Table 5: 8MM, Sources of Prevalence Data Used to Forecast the Diagnosed Prevalent Cases of AF
Table 6: 8MM, Sources of AF Subtype Data Used to Forecast the Diagnosed Prevalent Cases of AF by
Subtypes
Table 7: 8MM, Diagnosed Prevalent Cases of AF, Ages =40 Years, Both Sexes, N, 2013-2023
Table 8: 8MM, Diagnosed Prevalent Cases of AF, by Age, Both Sexes, N (Row %), 2013
Table 9: 8MM, Diagnosed Prevalent Cases of AF, by Sex, Ages =40 Years, N (Row %), 2013
Table 10: 8MM, Diagnosed Prevalent Cases of AF, by Clinical Subtypes, Both Sexes, N (Row %), 2013
1.2 List of Figures
Figure 1: 8MM, Diagnosed Prevalent Cases of AF, Ages =40 Years, Both Sexes, N, 2013-2023
Figure 2: 8MM, Diagnosed Prevalent Cases of AF, by Age, Both Sexes, N, 2013
Figure 3: 8MM, Diagnosed Prevalent Cases of AF, by Sex, Ages =40 Years, N, 2013
Figure 4: 8MM, Age-Standardized Diagnosed Prevalence (%) of AF, by Sex, Ages =40 Years, 2013
Figure 5: 8MM, Diagnosed Prevalent Cases of AF, by Clinical Subtypes, Both Sexes, N, 2013
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2819213/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
Web Address:
http://www.researchandmarkets.com/reports/2819213/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 3995
Electronic (PDF) Site License:
USD 7990
Electronic (PDF) Enterprisewide:
USD 11985
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World